MedTrace Logo

Creatine Supplementation in Patients With Intermittent Claudication.

NCT02993874 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2019-02-21

No results posted yet for this study

Summary

The aim of this study will be to verify the effect of creatine supplementation associated to clinical treatment of the functional capacity in patients with intermittent claudication.

Conditions

  • Intermittent Claudication

Interventions

DIETARY_SUPPLEMENT

Creatine

The experimental group will ingest for seven days (Loading - phase 1), 5g (4x/day) of creatine monohydrate associated with the clinical treatment (30-45 minutes of walking, 3 times a week). Subsequently, they will ingest for 49 days (Maintenance - phase 2), 3g (1x / day) creatine monohydrate associated with clinical treatment (30-45 minutes of walking, 3 times a week). They will be given guidance by telephone, so that they can reach the necessary recommendations for the study.

DIETARY_SUPPLEMENT

Placebo

The placebo group will ingest for seven days (Loading - phase 1), 5g (4x / day) of dextrose associated to clinical treatment (30-45 minutes of walking, 3 times per week). Subsequently, they will ingest for 49 days (Maintenance phase 2), 3g (1x / day) of dextrose associated with the clinical treatment (30-45 minutes of walking, 3 times a week). They will be given guidance by telephone, so that they can reach the necessary recommendations for the study.

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado do Amazonas

    collaborator UNKNOWN

  • State University of Maringá

    lead OTHER

Principal Investigators

  • Ademar Avelar, PhD · State University of Maringa

  • Raphael Ritti-Dias, PhD · Israel Institute of Education and Research Albert Einstein

  • Gabriel Cucato, PhD · Israel Institute of Education and Research Albert Einstein

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-26
Primary Completion
2019-02-28
Completion
2019-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02993874 on ClinicalTrials.gov